Literature DB >> 29049077

Persistence and Adherence to Psychostimulants, and Psychological Well-Being Up to 3 Years After Specialized Treatment of Adult Attention-Deficit/Hyperactivity Disorder: A Naturalistic Follow-Up Study.

Denise Bijlenga1, Semahat Kulcu, Trevor van Gellecum, Zeynep Eryigit, J J Sandra Kooij.   

Abstract

BACKGROUND: Little is known about the long-term persistence and adherence of psychostimulant use in adults with attention-deficit/hyperactivity disorder (ADHD) and its relationship to their psychological well-being.
METHODS: The persistence and adherence to psychostimulants and psychological well-being were examined in adults with ADHD in a naturalistic follow-up, starting directly after discharge from their specialized treatment of ADHD at an outpatient ADHD clinic. Ninety-six patients were included at the time of discharge, who were interviewed by telephone at 6 months, 1 year, and 3 years after discharge.
RESULTS: At the time of discharge, 78% used a psychostimulant prescribed by a psychiatrist. Of those on psychostimulants at the time of discharge, approximately half still used any of these psychostimulants 3 years after discharge. However, adherence rates were good for those who persisted to use psychostimulants. The female sex and middle educational level (relative to a higher educational level) were near-significantly related to nonpersistence, and having a higher educational level and the combined ADHD subtype were related to nonadherence. In turn, nonadherence was related to worse general functioning, lower mood, and poorer sleep quality.
CONCLUSIONS: The importance of adherence should be discussed at the time of discharge, especially with female ADHD patients, those with a higher educational level, and those with a combined ADHD subtype, because nonadherence is associated with poorer outcomes.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 29049077     DOI: 10.1097/JCP.0000000000000787

Source DB:  PubMed          Journal:  J Clin Psychopharmacol        ISSN: 0271-0749            Impact factor:   3.153


  4 in total

1.  Long-Term Tolerability and Safety of Pharmacological Treatment of Adult Attention-Deficit/Hyperactivity Disorder: A 6-Year Prospective Naturalistic Study.

Authors:  Dan Edvinsson; Lisa Ekselius
Journal:  J Clin Psychopharmacol       Date:  2018-08       Impact factor: 3.153

2.  Cognitive behavioural therapy in groups for medicated adults with attention deficit hyperactivity disorder: protocol for a randomised controlled trial.

Authors:  Mei-Rong Pan; Meng-Jie Zhao; Lu Liu; Hai-Mei Li; Yu-Feng Wang; Qiu-Jin Qian
Journal:  BMJ Open       Date:  2020-10-05       Impact factor: 2.692

3.  Five-year outcomes of ADHD diagnosed in adulthood.

Authors:  Elin Nylander; Orestis Floros; Timea Sparding; Eleonore Rydén; Stefan Hansen; Mikael Landén
Journal:  Scand J Psychol       Date:  2020-11-20

4.  The Association of Oral Stimulant Medication Adherence with Work Productivity among Adults with ADHD.

Authors:  William Spalding; Sepehr Farahbakhshian; Martine C Maculaitis; Eugenia Y Peck; Amir Goren
Journal:  J Atten Disord       Date:  2021-06-17       Impact factor: 3.256

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.